[Skip to Content]
[Skip to Content Landing]
Article
October 12, 1963

Hydroxystilbamidine vs Stilbamidine.

JAMA. 1963;186(2):115. doi:10.1001/jama.1963.03710020035010

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

—Guy Whitehead, PhD, of the Section of Publications, Mayo Clinic, has written that in the communication titled "Trigeminal Neuropathy and Neuritis," by Norman P. Goldstein, MD, Joseph A. Gibilisco, DDS, and Joseph G. Rushton, MD (184:458 [May 11]), untoward effects were erroneously attributed to hydroxystilbamidine isethionate. "The drug responsible was stilbamidine isethionate. Inasmuch as the hydroxy form of stilbamidine has been supposed not to produce such reactions, the misstatement can be disadvantageous to potential users."

First Page Preview View Large
First page PDF preview
First page PDF preview
×